18F-Fluorocholine PET/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma
Parathyroid carcinoma (PC) is a rare disease, with a frequency of 0.005% of all malignancies. Approximately 30% of patients will develop metastases at some point in the disease. Nonsecreting PC represents <10% of all PC and is harder to diagnose. Here, we report the case of a patient suffering from metastatic nonsecreting PC who has been (and still is) monitored for 4.5 years with 18F-fluorocholine PET/CT.
Authors
- Sylvie Zanetta (ORCID: https://orcid.org/0000-0003-2002-0255)
- Clément Drouet (ORCID: https://orcid.org/0000-0001-5606-8467)
- Margaux Brument
Institutions
- Centre Georges François Leclerc (FR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-03-10
- DOI
- https://doi.org/10.1097/rlu.0000000000005825
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43